Skip to content

IEMbase 0224: PDHX-related Pyruvate dehydrogenase E3-binding protein deficiency

Scope

Field Value
IEMbase ID 224
Nosology 5.1.04.01
Gene PDHX
External IDs OMIM:245349
Generated mapping MAPPED; Pyruvate_Dehydrogenase_Deficiency.yaml#E3-binding protein deficiency
Candidate DisMech targets Pyruvate_Dehydrogenase_Deficiency.yaml#E3-binding protein deficiency
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents this as PDHX-related pyruvate dehydrogenase E3-binding protein deficiency, with the alternate label pyruvate dehydrogenase component X deficiency. The record is autosomal recessive and treatability is marked yes.

The biochemical rows include increased alanine, ketones, lactate, lactate/pyruvate ratio, and pyruvate, with glucose recorded as normal. Clinical rows include developmental delay, drug-resistant epilepsy, hypotonia, and seizures. Characteristic rows include corpus-callosum agenesis, failure to thrive, lactic acidosis, and microcephaly. Treatments listed by IEMbase are thiamine and ketogenic diet.

DisMech phenotype coverage

Pyruvate_Dehydrogenase_Deficiency.yaml#E3-binding protein deficiency is the correct target. The local entry covers PDHX-related deficiency of the E3-binding protein/protein X component of the PDH complex, autosomal recessive inheritance, reduced pyruvate-to-acetyl-CoA flux, lactate and pyruvate accumulation, lactic acidosis, developmental delay, hypotonia, seizures, movement-disorder context, ketogenic diet, thiamine context, and molecular testing.

Concordance and completeness

Judgement: correct subtype-level mapped target with high concordance.

IEMbase and DisMech agree on PDHX/E3-binding protein identity, PDH-complex subtype placement, the lactate-pyruvate biochemical pattern, lactic acidosis, developmental delay, hypotonia, seizure involvement, ketogenic diet, and thiamine. IEMbase adds useful compact rows for drug-resistant epilepsy, corpus-callosum agenesis, failure to thrive, microcephaly, and alanine/ketone measurements.

Curation actions

  • Keep this record mapped to Pyruvate_Dehydrogenase_Deficiency.yaml#E3-binding protein deficiency.
  • No mapping correction is needed.
  • Use IEMbase as subtype-specific confirmation for PDHX seizure severity and malformation/growth features.